Dr. Lekha Mikkilineni is a physician-scientist and Assistant Professor of Medicine at Stanford University, specializing in cancer immunotherapy and cell-based therapies such as CAR-T, with a particular focus on multiple myeloma. As a clinical-translational researcher, she collaborates across disciplines to advance the development, safety, and effectiveness of novel cellular therapies.

Areas of Special Interest:

• Multiple Myeloma
• Cancer immunotherapy
• CAR-T  and cell-based therapies
• Clinical translational research
• Safety and long-term outcomes of novel cellular therapies